Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

It's Time to Use MRD for Clinical Decision Making: MRD as a Surrogate Marker for PFS/OS, for Maintenance Decision Making, Renal Allografting Patient Qualification, and Solitary Plasmacytomas Definition

35 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login